Loading
A phase 2 trial of Electrochemotherapy in Vulvar cancer, run by IRCCS Azienda Ospedaliero-Universitaria di Bologna, now recruiting.
Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer is a phase 2 interventional study registered as NCT05395962 by IRCCS Azienda Ospedaliero-Universitaria di Bologna, with 92 participants planned, started 2022-04-08 and due to reach its primary completion in 2025-04-07. Interventions recorded: Carboplatin, Bleomycin. Conditions recorded: Vulvar Cancer.
Linked to the technology Electrochemotherapy because the registry's title names it ("electrochemotherapy") and Vulvar cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Electrochemotherapy, Vulvar cancer and the tag pipeline.
Shares Electrochemotherapy and the tag pipeline.
Shares Bleomycin and the tag pipeline.
Shares Vulvar cancer and the tag pipeline.
Shares Carboplatin and the tag pipeline.
Shares Carboplatin and the tag pipeline.
Shares Carboplatin and the tag pipeline.
Shares Carboplatin and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/